6505--Radioactive (Xofigo) Isotopes Notice of Intent to Sole Source
ID: 36C25624Q0041Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF256-NETWORK CONTRACT OFFICE 16 (36C256)RIDGELAND, MS, 39157, USA

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/2cae128c7040471ca5be1bd196e4fd72/view
Timeline
    Description

    Special Notice: VETERANS AFFAIRS, DEPARTMENT OF intends to negotiate a sole source Firm-Fixed Price contract for the procurement of Radioactive (Xofigo) Isotopes- RADIUM RA 223 DICHLORIDE INJECTION for the Michael E. DeBakey VA Medical Center located in Houston, Texas with Cardinal Health, Inc. This service is typically used for medical purposes at the VA Medical Center.

    Point(s) of Contact
    Jeneice MatthewsContract Specialist
    713-791-1414 ext. 44002
    jeneice.matthews@va.gov
    Files
    Title
    Posted
    36C25624Q0041.docx
    36C25624Q0041 Special Notice.pdf
    Lifecycle
    Title
    Type
    6505--Radioactive (Xofigo) Isotopes Notice of Intent to Sole Source
    Currently viewing
    Special Notice
    Similar Opportunities
    Notice of Intent to Sole Source – Cardinal Health, Inc.
    Buyer not available
    The National Institutes of Health (NIH) intends to award a fixed-price purchase order to Cardinal Health, Inc. for the procurement of Floxuridine Vials, specifically for patient care at the NIH Clinical Center in Bethesda, Maryland. The requirement includes 10 units of Floxuridine for Injection, catalog number 0143-9270-01, which is exclusively distributed by Cardinal Health, Inc. in the United States, highlighting the critical nature of this medication for patient treatment. Interested parties may express their interest and capabilities to Kristin Nagashima at kristin.nagashima@nih.gov by February 10, 2025, at 4 PM EST, as this acquisition is being conducted under the Simplified Acquisition Procedures of the Federal Acquisition Regulation.
    Award Notice - 36C24425P0281 Urgent Bridge Ga-68
    Buyer not available
    The Department of Veterans Affairs is issuing an award notice for a federal contract titled "Urgent Bridge Ga-68," specifically for the procurement of Emergency Bridge for Gallium Ga68. This contract, awarded to Nuclear Diagnostic Products, Inc., amounts to $34,371.90 and is crucial for ensuring the availability of essential medical supplies for veterans' healthcare. The contract was officially awarded on February 3, 2025, and falls under the NAICS code 325412, indicating its classification within the pharmaceutical preparation manufacturing sector. For further inquiries, interested parties can contact Contracting Officer Victoria Droz at Victoria.Droz@va.gov or by phone at 814-515-4454.
    S205--RFQ: Pharmaceutical Waste Treatment Disposal Services (MEDVAMC)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for Pharmaceutical Waste Treatment Disposal Services at the Michael E. DeBakey VA Medical Center in Houston, Texas, including its outpatient clinics in Beaumont and Lufkin. The procurement requires contractors to provide all necessary labor, tools, materials, and equipment for the collection, treatment, and disposal of controlled substance pharmaceutical waste, ensuring compliance with federal, state, and local hazardous waste regulations. This contract, set as a firm-fixed price with a base year and four optional years, emphasizes the importance of secure and effective waste management solutions in healthcare facilities. Interested Service-Disabled Veteran-Owned Small Businesses (SDVOSB) must be registered in the System for Award Management (SAM) and submit their proposals by February 11, 2025; for further inquiries, contact Contract Specialist Quentin Chew at Quentin.Chew@va.gov or (713) 791-1414.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) designated as 36E79725R0021 for the procurement of Rituximab and its biosimilars, aimed at ensuring a reliable supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will span one year with four additional one-year options, emphasizing the necessity of maintaining an uninterrupted supply chain for these critical medications. Offerors must provide the exact product names along with unique National Drug Codes (NDC), with estimated annual requirements of 17,858 vials of Rituximab 10mg/ml and 25,111 vials of the 50mg/ml variant. The solicitation is expected to be published around February 17, 2025, with a closing date around March 4, 2025; interested parties should direct inquiries to Deb Fassl at Deborah.Fassl@va.gov.
    6505--Bevacizumab Injection
    Buyer not available
    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    Q522--Angio-Interventional Radiology Services 614 Long Term Contract
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to provide Angio-Interventional Radiology services at the Memphis VA Medical Center through a long-term contract. The procurement aims to secure on-site services from board-certified Angio-Interventional Radiology Physicians, adhering to standards set by the American College of Radiology, with a contract structure consisting of one base year and four optional one-year extensions, projected to commence on October 1, 2025. This opportunity is critical for ensuring high-quality patient care and compliance with VA and HIPAA regulations, emphasizing the importance of qualified personnel and adherence to performance standards. Interested parties must submit their capabilities and qualifications, including Small Business certification and active registration in the System for Award Management (SAM), to Contracting Specialist Laura Edelman at laura.edelman@va.gov by the specified deadline.
    6505--Mycophenolate Mofetil RFP
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0010 for the procurement of Mycophenolate Mofetil tablets and capsules, intended for use by the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The procurement aims to secure a reliable source of supply for these essential medications, with a contract term of one year and the option to extend for four additional years, emphasizing the importance of uninterrupted access to critical pharmaceuticals for veterans and associated federal programs. Interested offerors must comply with specific packaging requirements, including child-resistant closures for smaller bottles, and are encouraged to check the designated URL for updates, with the solicitation expected to be issued around February 14, 2025, and offers accepted until February 28, 2025. For inquiries, potential bidders can contact Amber Zavala at amber.zavala@va.gov or by phone at (708) 786-5245.
    6530--RADIOLOGY AI SOFTWARE
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking qualified suppliers for a Commercial Off-the-Shelf (COTS) Radiology AI Software that will enhance healthcare delivery for veterans by integrating with the VA’s Electronic Medical Health Record (EMHR). The software must utilize AI capabilities for various diagnostic applications, including bone fracture detection, neuroimaging support, and breast cancer screening, while ensuring compliance with VA security directives and providing quality assurance functionalities. This initiative is crucial for improving operational efficiency within Radiology Services and ultimately enhancing patient care for veterans. Interested vendors are encouraged to submit their qualifications, business status, and general pricing by February 17, 2024, to the Contracting Officer, Anette Doan, at Anette.Doan@va.gov.
    COMPOUDING OF CUSTOMIZED PARENTERAL NURTITION
    Buyer not available
    The Department of Veterans Affairs, specifically the Memphis VA Medical Center, is seeking to negotiate a Sole Source Award with An I.V., LLC for the compounding of customized parenteral nutrition (PN) products. The procurement aims to provide same-day delivery of patient-specific parenteral nutrition compounds, with orders accepted until 3 PM for delivery by 7 PM, fulfilling an annual requirement of approximately 445 bags over a five-year period from February 2025 to September 2029. This service is critical for patients requiring specialized nutritional support, and the selected vendor must comply with stringent quality assurance standards and federal regulations, including accreditation by the Pharmacy Compounding Accreditation Board. Interested parties must submit their capabilities by 12:00 PM CST on February 6, 2025, to the Contract Specialist, William Blassingame, at william.blassingame@va.gov, as no formal solicitation will be issued.
    6525--NX EQ Ultrasound Guided Fusion Biopsy System (VA-25-00042216)
    Buyer not available
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify qualified vendors capable of supplying an Ultrasound Guided Fusion Biopsy System, specifically the Philips Healthcare UroNav MR or equivalent. The procurement aims to establish a Requirements Contract for nationwide delivery of the system to VA medical centers, with an anticipated duration of one base year and four optional extension periods. This advanced imaging system is crucial for enhancing minimally invasive biopsy procedures, providing real-time imaging and various biopsy approaches, while ensuring compliance with FDA regulations. Interested vendors must submit their responses, including technical literature and service plan details, to Alex Beck at Alex.Beck1@va.gov by the specified deadline, as this notice is part of the VA's ongoing market research efforts.